D.E. Shaw & Co
ARAV

D.E. Shaw & Co’s Aravive, Inc. Common Stock ARAV Stock Holding History

D.E. Shaw & Co’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,637
Closed -$73K – 4006
2018
Q4 		$73K Sell
20,637
-14,574
-41% -$83.8K ﹤0.01% 3665
2018
Q3 		$295K Buy
35,211
+5,693
+19% +$60K ﹤0.01% 3369
2018
Q2 		$359K Buy
29,518
+13,532
+85% +$139K ﹤0.01% 3286
2018
Q1 		$158K Buy
15,986
+9,431
+144% +$106K ﹤0.01% 3361
2017
Q4 		$87K Buy
+6,555
New +$84.4K ﹤0.01% 3501
2017
Q2 		– Sell
-4,889
Closed -$626K – 3587
2017
Q1 		$626K Buy
4,889
+2,352
+93% +$248K ﹤0.01% 2610
2016
Q4 		$227K Sell
2,537
-185
-7% -$14K ﹤0.01% 3227
2016
Q3 		$200K Sell
2,722
-1,620
-37% -$117K ﹤0.01% 3201
2016
Q2 		$288K Sell
4,342
-1,694
-28% -$96.3K ﹤0.01% 3036
2016
Q1 		$290K Buy
+6,036
New +$320K ﹤0.01% 3031
2015
Q3 		– Sell
-2,574
Closed -$235K – 3951
2015
Q2 		$235K Buy
+2,574
New +$261K ﹤0.01% 3516

Other funds holding ARAV

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

D.E. Shaw & Co's ARAV Position: Q1 2019 in Review

D.E. Shaw & Co sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2019, closing a stake of 20,637 shares — an estimated $73K sold.

D.E. Shaw & Co first reported a position in ARAV in Q2 2015 and held it in 11 quarters. The position peaked at $626K in Q1 2017. 30 funds tracked by Wall St. Rank hold ARAV as of Q1 2019.

  • D.E. Shaw & Co reported no remaining Aravive, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 20,637 Aravive, Inc. Common Stock shares in Q1 2019, an estimated $73K.
  • D.E. Shaw & Co first reported a position in Aravive, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
  • D.E. Shaw & Co's Aravive, Inc. Common Stock position peaked at $626K in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2019.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.